Onconetix, Inc. (ONCO)

NASDAQ: ONCO · USD

$0.58

+0.11 (+22.5%)· Recorded snapshot

Market cap	2.3M
Revenue (ttm)	645.8K
Net income (ttm)	-10.2M
EPS (ttm)	-$17.2
Shares out	3.9M
Volume	44,150,566
Beta	2.61

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 645.8K
Net income (ttm): -10.2M
EPS (ttm): -$17.2
Market cap: 2.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	ホールド

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-105.2

P25 n/aP50 n/aP75 n/a

ROIC-33.9

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All ONCO indicators

Market & fundamental data

Available fields

196

Groups with data

Currency

USD

Showing 196 of 196 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001782107
Company name	Onconetix, Inc.
Country	United States
Country code	US
CUSIP number	68237Q401
Earnings date	2026-11-12
Earnings time	amc
Employees	2
Employees change	-3
Employees growth	-60%
Enterprise value	$-3.5M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2018
Industry	Biotechnology
IPO date	2022-02-18
Is primary listing	Yes
Is SPAC	No
ISIN number	US68237Q4010
Last 10-K release date	2026-03-13
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2026-05-21
Last stock split type	Reverse
Market cap	$2.3M
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	No
Price	$0.58
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	ONCO
U.S. state	Ohio
Website	https://www.onconetix.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-2,950.27%
FCF / EV yield	312.93%
FCF yield	-418.84%
P/B ratio	0.13x
P/S ratio	3.81x
Price / tangible book value	0.64x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	80.4%
Operating margin	-1,190.29%
Pretax margin	-1,578.71%
Profit per employee	$-5.1M
Revenue per employee	$322,912
ROA	-27.03%
ROA (5Y)	-31.17%
ROCE	-57.02%
ROE	-105.23%
ROE (5Y)	-366.64%
ROIC	-33.93%
SBC / revenue	6.77%
Tax / revenue	0.08%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	2
EPS growth years	2
Gross profit growth	-41.11%
Gross profit growth (Q)	-93.9%
Net income growth years	1
Revenue growth	-51.33%
Revenue growth (Q)	-83.92%
Revenue growth (QoQ)	-20.21%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	$14,753
EBIT	$-7.7M
EBITDA	$-7.7M
EPS	$-17.16
FCF per share	$-2.61
Financing cash flow	$15.6M
Free cash flow	$-10.3M
Free cash flow minus SBC	$-10.4M
Gross profit	$519,226
Income taxes	$525
Net borrowing	$-4.6M
Net cash flow	$5.7M
Net income	$-10.2M
Operating cash flow minus SBC	$-10.4M
Operating income	$-7.7M
Revenue	$645,824
Stock-based compensation	$43,693

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-12.46
Book value per share	$3.55
Debt / equity	0.01
Goodwill	$9.6M
Interest coverage	-24.72
Long-term assets	$9.9M
Long-term liabilities	$14,039
Net cash (debt)	$5.8M
Net cash / market cap	233.85%
Net debt / equity	-0.43
Piotroski F-Score	3
Property, plant and equipment	$65,389
Shareholders' equity	$13.5M
Tangible book value	$3.9M
Tangible book value per share	$1.01
Total assets	$16.4M
Total cash	$5.9M
Total debt	$187,128
Total liabilities	$3M
WACC	26.55%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.04
Current assets	$6.5M
Current liabilities	$2.9M
Current ratio	2.21
Inventory turnover	0.7
Net working capital	$-2.2M
Quick ratio	2.04
Working capital	$3.6M
Working capital turnover	-0.16

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$2.86
1D price change	22.52%
1M price change	-40.8%
1M total return	-40.8%
1W price change	50.05%
1W total return	50.05%
1Y price change	-99.66%
1Y return CAGR	-99.66%
1Y total return	-99.66%
20-day SMA	$0.55
200-day SMA	$14.65
3M price change	-25.08%
3M total return	-25.08%
3Y price change	-100%
3Y return CAGR	-97.78%
3Y total return	-100%
50-day SMA	$0.67
50-day SMA vs 200-day SMA	50under200
52-week high	$200.00
52-week high date	2025-10-30
52-week low	$0.34
52-week low date	2026-10-27
6M price change	-91.78%
6M total return	-91.78%
After-hours change	2.75%
After-hours close	$0.58
After-hours price	$0.60
All-time high	$15,452,876.38
All-time high date	2022-02-22
All-time low	$0.34
All-time low date	2026-10-27
Average true range (ATR)	$0.10
Average volume	5.1M
Beta (1Y)	0.72
Beta (2Y)	1.91
Beta (5Y)	2.61
Change from 52-week high	-99.71%
Change from 52-week low	69.88%
Change from all-time high	-100%
Change from all-time low	78.15%
Change from open	14.31%
Day's gap	7.18%
Dollar volume	$25.7M
High price	$0.67
Low price	$0.50
Monthly RSI	13.9
Open price	$0.51
Position in 52-week range	46.71%
Premarket change	7.4%
Premarket close	$0.47
Premarket price	$0.51
Premarket volume	402K
Previous close	$0.47
Price vs 150-day SMA	-78.69%
Price vs 20-day SMA	11.03%
Price vs 200-day SMA	-95.84%
Price vs 50-day SMA	-8.3%
Relative volume	8.63
Return from IPO open	-100%
Return from IPO price	-93.08%
RSI	52.2
Sharpe ratio	-2.32
Sharpe ratio (3Y)	-1.3
Sortino ratio	-2.95
Sortino ratio (3Y)	-2.03
Volume	44.2M
Weekly RSI	28.92
YTD price change	-99.22%
YTD total return	-99.22%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3.9M
Float percentage	100%
Shares change (QoQ)	3,468.28%
Shares held by insiders	0%
Shares held by institutions	7.39%
Shares outstanding	3.9M
Short % of float	12.4%
Short % of shares	12.4%
Short ratio	0.1 days

Other indicators

Additional ticker metrics that do not fit the primary research groupings.

Metric	Value
Page views	367

Deeper analysis on ONCO

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this ONCO report

Is a complete ONCO research report available?

No complete published report is available for Onconetix, Inc. (ONCO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Onconetix, Inc. (ONCO)

Price

Financial snapshot

Fair-value bridge

Latest news · ONCO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All ONCO indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on ONCO

Frequently asked questions